COVID-19-Associated Mucormycosis: A Matter of Concern Amid the SARS-CoV-2 Pandemic
Mucormycosis is an invasive fungal infection caused by fungi belonging to order Mucorales. Recently, with the increase in COVID-19 infections, mucormycosis infections have become a matter of concern globally, because of the high morbidity and mortality rates associated with them. Due to the associat...
Main Authors: | Pankaj Chandley, Priyanka Subba, Soma Rohatgi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-08-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/10/8/1266 |
Similar Items
-
Disseminated mucormycosis in a paediatric patient: Lictheimia corymbifera successfully treated with combination antifungal therapy
by: Anita Campbell, et al.
Published: (2014-10-01) -
Clinical and microbiological features and outcomes of mucormycosis in critically ill patients
by: Kathrin Rothe, et al.
Published: (2021-08-01) -
Necrotizing Mucormycosis of Wounds Following Combat Injuries, Natural Disasters, Burns, and Other Trauma
by: Thomas J. Walsh, et al.
Published: (2019-07-01) -
Host-parasite interactions during Plasmodium infection: Implications for immunotherapies
by: Pankaj Chandley, et al.
Published: (2023-01-01) -
The impact of SARS-CoV-2 on the sudden onset of Mucormycosis in the Indian subcontinent-A review
by: Shakila Mahesh, et al.
Published: (2022-01-01)